Hans van Weenen

496 total citations
9 papers, 351 citations indexed

About

Hans van Weenen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Hans van Weenen has authored 9 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Oncology. Recurrent topics in Hans van Weenen's work include Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cancer Treatment and Pharmacology (3 papers) and Electron Spin Resonance Studies (3 papers). Hans van Weenen is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cancer Treatment and Pharmacology (3 papers) and Electron Spin Resonance Studies (3 papers). Hans van Weenen collaborates with scholars based in Netherlands. Hans van Weenen's co-authors include Herbert M. Pinedo, Mariet M. de Planque, J. G. McVie, J. Lankelma, J.M.S. van Maanen, W.W. ten Bokkel Huinink, W. J. F. van der Vijgh, W. J. van Oort, H.A.J. Govers and Gerrit Voortman and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Journal of Pharmaceutical and Biomedical Analysis and Investigational New Drugs.

In The Last Decade

Hans van Weenen

8 papers receiving 318 citations

Peers

Countries citing papers authored by Hans van Weenen

Since Specialization

Citations

This map shows the geographic impact of Hans van Weenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans van Weenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans van Weenen more than expected).

Fields of papers citing papers by Hans van Weenen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans van Weenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans van Weenen. The network helps show where Hans van Weenen may publish in the future.

Co-authorship network of co-authors of Hans van Weenen

This figure shows the co-authorship network connecting the top 25 collaborators of Hans van Weenen. A scholar is included among the top collaborators of Hans van Weenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans van Weenen. Hans van Weenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Sustainable chemistry: an analysis of the concept and its integration in education 2001 ·International Journal of Sustainability in Higher Education ·(unknown), H.A.J. Govers, (unknown), Hans van Weenen	7
2	Towards a vision of a sustainable university 2000 ·International Journal of Sustainability in Higher Education ·Hans van Weenen	183
3	Design for sustainable development : practical examples of SMEs 1999 ·Medical Entomology and Zoology ·Hans van Weenen	2
4	Design for sustainable development : guides and manuals 1997 ·Medical Entomology and Zoology ·Hans van Weenen	8
5	Analysis of Doxorubicin, 4′-Epidoxorubicin, and Their Metabolites by Liquid Chromatography 1986 ·Journal of Pharmaceutical Sciences ·Hans van Weenen, (unknown), (unknown), J. Lankelma, W. J. F. van der Vijgh, Herbert M. Pinedo	17
6	Handling of biological samples in the determination of the anti-neoplastic drug mitomycin C 1985 ·Journal of Pharmaceutical and Biomedical Analysis ·Jan den Hartigh, Gerrit Voortman, W. J. van Oort, Hans van Weenen, Herbert M. Pinedo	8
7	Pharmacokinetics of carminomycin in man: Biweekly schedule vs single dose every three weeks 1984 ·European Journal of Cancer and Clinical Oncology ·Hans van Weenen, Herbert M. Pinedo, Mariet M. de Planque, W.W. ten Bokkel Huinink, J. G. McVie, J. Lankelma	2
8	Metabolism of 4′-modified analogs of doxorubicin. Unique glucuronidation pathway for 4′-epidoxorubicin 1984 ·European Journal of Cancer and Clinical Oncology ·Hans van Weenen, J.M.S. van Maanen, Mariet M. de Planque, J. G. McVie, Herbert M. Pinedo	55
9	Pharmacokinetics of 4′-epi-doxorubicin in man 1983 ·Investigational New Drugs ·Hans van Weenen, J. Lankelma, (unknown), J. G. McVie, W.W. ten Bokkel Huinink, Mariet M. de Planque, Herbert M. Pinedo	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact